UnitedHealth Group Incorporated (UNH) Upgraded to “Buy” at ValuEngine

0
4

UnitedHealth Group Incorporated (NYSE:UNH) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Friday, September 1st.

A number of other research analysts have also issued reports on UNH. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target on the stock in a research note on Monday, May 15th. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price target on the stock in a research note on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. Finally, Morgan Stanley increased their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. One equities research analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $203.41.

Shares of UnitedHealth Group (UNH) traded up 0.23% during trading on Friday, hitting $198.18. 4,198,691 shares of the company’s stock were exchanged. The stock has a market cap of $191.61 billion, a P/E ratio of 23.81 and a beta of 0.63. UnitedHealth Group has a one year low of $133.03 and a one year high of $200.76. The firm has a 50-day moving average price of $195.28 and a 200-day moving average price of $180.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.96 EPS. Equities research analysts expect that UnitedHealth Group will post $9.87 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Upgraded to “Buy” at ValuEngine” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://ledgergazette.com/2017/09/16/unitedhealth-group-incorporated-unh-upgraded-to-buy-at-valuengine.html.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last three months, insiders sold 25,600 shares of company stock valued at $4,962,694. Insiders own 0.89% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Intl Fcstone Inc. acquired a new position in UnitedHealth Group in the 2nd quarter valued at $2,324,000. RNC Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after purchasing an additional 13 shares during the period. HWG Holdings LP grew its stake in shares of UnitedHealth Group by 13.5% during the 2nd quarter. HWG Holdings LP now owns 6,367 shares of the healthcare conglomerate’s stock worth $1,181,000 after purchasing an additional 756 shares during the period. WFG Advisors LP boosted its position in shares of UnitedHealth Group by 14.9% in the 2nd quarter. WFG Advisors LP now owns 6,350 shares of the healthcare conglomerate’s stock worth $1,177,000 after buying an additional 825 shares in the last quarter. Finally, Cookson Peirce & Co. Inc. purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $204,000. 86.21% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com’s FREE daily email newsletter.